J.Jill, Inc. financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data J.Jill, Inc. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2017	FY2020	FY2018	FY2019	FY2020	FY2021	FY2022	FY2024	FY2024	FY2025
Revenue	698	706	706	691	427	585	619	608	611	597
Cost of revenue	234		246	263	181	191	193	177	181	187
Gross profit	464		460	429	246	394	425	431	430	410
Selling, general and administrative	395		399	407	343	336	345	345	353	358
General and administrative							82.3	80.7	82.1	77.8
Operating income	69.2		61.2	-112	-164	58.7	78.7	86.1	75.7	50.6
Interest expense	19.3		19.9	20.1			17.2	25.7	15.7	10.4
Pre-tax income	49.9		42.2	-132	-188	-20.1	58.7	49.4	54	39.1
Income tax	-5.44		11.6	-3.02	-48.2	8.02	16.5	13.2	14.5	11.2
Net income	55.4		30.5	-129	-139	-28.1	42.2	36.2	39.5	27.9
EBITDA	104		98	-74.1	-130	88	104	109	97	71.8
EPS, basic	6.60		3.57	-14.69	-15.22	-2.26	3.03	2.56	2.64	1.84
EPS, diluted	6.35		3.45	-14.69	-15.22	-2.26	2.95	2.51	2.61	1.82
Shares, basic (weighted)	8.39		8.55	8.75	9.16	12.4	13.9	14.1	15	15.2
Shares, diluted (weighted)	8.71		8.85	8.75	9.16	12.4	14.3	14.4	15.1	15.3
Dividend per share									0.21	0.32

Balance sheet

	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2024	FY2024	FY2025
Cash and equivalents	26	66.2	21.5	4.41	36	87.1	62.2	35.4	41
Receivables	4.73	4.01	7.41	7.79	5.81	7.04	5.04	5.02	4.32
Inventory	80.6	77.3	72.6	58	56	50.6	53.3	61.3	70.1
Other current assets	2.05	3.54	1.32	0.62	0.52	0.55	0.54	0.79	1.61
Total current assets	132	175	123	113	123	160	138	122	141
Property, plant and equipment	118	118	108	73.9	57.3	53.5	50.4	47	50.2
Lease right-of-use assets			211	161	131	119	108	112	129
Goodwill	197	197	77.6	59.7	59.7	59.7	59.7	59.7	59.7
Intangible assets	149	136	113	89	80.7	73.2	66.2	61	56.3
Other non-current assets	0.68	0.45	1.65	0.2	0.12	1.02	1.79	7.33	7.27
Total assets	598	627	634	497	452	466	428	418	450
Accounts payable	54	55	43.1	56.3	49.9	39.3	41.1	52	57.7
Short-term debt	2.8	2.8	2.8	13.9	7.69	3.42	35.4		1.88
Total current liabilities	106	103	122	152	139	127	155	127	131
Long-term debt	239	237	231	229	202	205	121		71.4
Lease liabilities			209	179	143	123	103	105	111
Other non-current liabilities	27.6	30.8	1.95	2.05	1.73	1.25	1.38	1.26	1
Total liabilities	418	413	595	594	497	467	391	312	329
Total debt	242	240	231	243	210	209	156		73.3
Paid-in capital	117	122	125	129	210	212	213	243	241
Retained earnings	61.5	91.7	-87	-226	-255	-212	-176	-137	-109
Treasury stock								-0.52	-10.9
Shareholders' equity	179	214	38.6	-96.9	-44.7	-0.22	37.2	106	121
Total equity	179	214	38.6	-96.9	-44.7	-0.22	37.2	106	121
Total liabilities and equity	598	627	634	497	452	466	428	418	450
Shares outstanding	8.75	43.7	8.86	9.63	10	10.2	10.6	15.3	14.9

Cash flow statement

	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2024	FY2024	FY2025
Net income	55.4	30.5	-129	-139	-28.1	42.2	36.2	39.5	27.9
Depreciation and amortization	35	36.7	37.9	33.7	29.3	25.8	22.9	21.3	21.2
Stock-based compensation	0.78	4.01	4.6	2.16	2.61	3.51	3.76	6.51	5.38
Deferred income tax	-27.2	-4.32	-10.8	-17.2	-3.13	-0.65	0.91	-1.58	5.01
Change in receivables	-0.88	0.73	-3.4	-0.39	1.98	-1.23	2	0.03	0.7
Change in inventory	-14	3.24	4.02	14.6	2.01	5.44	-2.67	-8.12	-8.77
Change in payables	15.3	0.47	-11.3	13.4	-6.22	-10.6	1.8	10.7	5.74
Cash from operations	76.4	67.5	32.7	-34.8	75	74.4	63.3	65	42.1
Capital expenditures	-38.4	-24.7	-18.2	-1.58	-2.2	-9.19	-10.7	-14.3	-16.9
Cash from investing	-38.4	-24.7	-18.2	-3.81	-5.47	-15.1	-16.9	-17.8	-18.9
Debt issued							164		74.3
Debt repaid	-27.7	-2.8	-7.8	-2.8	-26.4	-7.02
Stock issued								29.5
Share buybacks								-0.52	-10.4
Dividends paid			-50.2					-2.9	-4.86
Cash from financing	-25.5	-2.57	-59.1	21.5	-38	-8.26	-71.3	-74	-17.6
Net change in cash	12.5	40.2	-44.7	-17.1	31.6	51.1	-24.9	-26.8	5.59
Free cash flow	38	42.8	14.4	-36.4	72.8	65.2	52.6	50.8	25.2
Interest paid	16.4	18	18,107	14.2	14	11.7	25.9	15.4	8.95
Income taxes paid	20.5	23.1	7,187	0.02	9.28	19.7	13.4	15.6	10.8

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to August 1, 2026; growth uses fiscal years. Valuation uses the share price of $24.63 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	70.0%	Gross profit / revenue.
Operating margin	8.1%	Operating income / revenue.
EBITDA margin	11.7%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	6.6%	Pre-tax income / revenue.
Net margin	4.6%	Net income / revenue.
FCF margin	8.3%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	11.1%	Cash from operations / revenue.
Effective tax rate	29.6%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	19.4%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	5.9%	Net income / average total assets.
Return on invested capital (ROIC)	24.8%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue	61.7%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	1.0%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	2.8%	Capital expenditures / revenue.
D&A / revenue	3.5%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	-2.3%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	-1.2%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	6.9%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	-4.7%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	-1.2%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	10.8%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	-33.1%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	-13.7%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA growth, 1y	-26.0%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	-11.8%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income growth, 1y	-29.4%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	-12.9%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS growth, 1y	-30.3%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	-14.9%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow growth, 1y	-35.2%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	-17.3%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow growth, 1y	-50.4%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	-27.2%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share growth, 1y	52.4%	Dividend per share vs the same period a year earlier. Only from a positive base.
Book value growth, 1y	14.9%	Book value vs the same period a year earlier. Only from a positive base.
Total assets growth, 1y	7.8%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	-1.2%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	-2.0%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	1.3%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	2.4%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	10.9%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	1.30x	Current assets / current liabilities.
Quick ratio	0.69x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.64x	(Cash + short-term investments) / current liabilities.
Debt / equity	0.52x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	15.8%	Total debt / total assets.
Liabilities / assets	69.5%	Total liabilities / total assets.
Net debt	-$4.4M	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	-0.06x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage	5.51x	Operating income / interest expense.
Working capital	$35.6M	Current assets - current liabilities.
Goodwill and intangibles / assets	24.8%	(Goodwill + intangible assets) / total assets.
Tangible book value	$26.1M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	1.28x	Revenue / average total assets.
Inventory turnover	3.35x	Cost of revenue / average inventory.
Days inventory	109 days	365 x average inventory / cost of revenue.
Receivables turnover	100x	Revenue / average receivables.
Days sales outstanding	4 days	365 x average receivables / revenue.
Days payables	87 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	25 days	Days inventory + days sales outstanding - days payables.
FCF conversion	179.2%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	25.6%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$1.80	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$39.02	Revenue / diluted weighted shares.
FCF per share	$3.23	Free cash flow / diluted weighted shares.
Operating cash flow per share	$4.34	Cash from operations / diluted weighted shares.
Book value per share	$9.41	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$1.76	Tangible book value / shares outstanding.
Cash per share	$5.18	(Cash + short-term investments) / shares outstanding.
Payout ratio	18.8%	Dividends paid / net income, when net income is positive.
Dividends / FCF	10.5%	Dividends paid / free cash flow, when free cash flow is positive.
Buybacks / FCF	16.8%	Share buybacks / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$368.3M	Share price x shares outstanding.
Enterprise value	$363.9M	Market cap + total debt - cash - short-term investments.
P/E	13.6x	Market cap / net income. Only when net income is positive.
P/S	0.63x	Market cap / revenue.
P/B	2.63x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	14.1x	Market cap / tangible book value, when positive.
P/FCF	7.57x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	5.63x	Market cap / cash from operations, when positive.
EV/Sales	0.62x	Enterprise value / revenue.
EV/EBIT	7.61x	Enterprise value / operating income, when both are positive.
EV/EBITDA	5.30x	Enterprise value / EBITDA, when both are positive.
EV/FCF	7.48x	Enterprise value / free cash flow, when both are positive.
FCF yield	13.2%	Free cash flow / market cap.
Earnings yield	7.4%	Net income / market cap (the inverse of P/E).
Dividend yield	1.4%	Dividends paid over the period / market cap.
Shareholder yield	3.6%	(Dividends paid + share buybacks) / market cap.

What was J.Jill, Inc.'s revenue in fiscal 2025?

J.Jill, Inc. reported revenue of $596.5M for fiscal 2025, 2.3% lower than the year before.

Was J.Jill, Inc. profitable in fiscal 2025?

Yes. Net income was $27.9M, a net margin of 4.7%.

How much free cash flow did J.Jill, Inc. generate in fiscal 2025?

Cash from operations of $42.1M minus capital expenditures of $16.9M left free cash flow of $25.2M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to J.Jill, Inc.